Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.

Bioscience reports - 28 Aug 2020

Lvu Wen, Fei Xu, Chen Cheng, Zhang Bo

Abstract excerpt

Glioma is the common histological subtype of malignancy in central nervous system, with a high morbidity and mortality. Cancer stem cells (CSCs) play an important role in regulating the tumorigenesis and progression of glioma; however, the prognostic biomarkers and therapeutic targets associated with CSC characteristics have not been fully acknowledged in glioma. In order to identify the prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chloride Channels
Share to Glioma
Share to Isocitrate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplastic Stem Cells

Share to Nomograms

Share to Protein-Lysine 6-Oxidase

Share to Receptors, Thrombin

Share to RNA-Seq

Source

Open in PubMed Open full text

Identifiers

PMID: 32725165
DOI: 10.1042/BSR20201037
PMCID: PMC7418212

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.PMID 32725165Read ↗

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness IndicesSemantic proximity Read ↗

In Silico Analysis and Characterization of Differentially Expressed Genes to Distinguish Glioma Stem Cells from Normal Neural Stem CellsSemantic proximity Read ↗

Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment responseSemantic proximity Read ↗

Glioma stem cells: drivers of tumor progression and recurrenceSemantic proximity Read ↗

Weighted Gene Coexpression Network Analysis Reveals Cancer Stem Cell-Associated Metabolic Gene Signature in GliomaSemantic proximity Read ↗

A Glioma Stem Cell–Associated Transcriptomic Program Predicts Survival Across Adult and Pediatric High-Grade GliomasSemantic proximity Read ↗

Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.Semantic proximity Read ↗

Identification of a Cancer Stemness Driven Prognostic Model and Therapeutic Drug Targets by Machine Learning in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of stem cell-related gene signature and integrative analyses in patients with lower-grade gliomasSemantic proximity Read ↗

Correlation of Hepatocellular Carcinoma Stemness Indices and Clinical Characteristics and PrognosisSemantic proximity Read ↗

Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.Semantic proximity Read ↗

Promising Prognosis Marker Candidates on the Status of Epithelial–Mesenchymal Transition and Glioma Stem Cells in GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.